EsoBiotec is a startup based in Belgium, most recent round Acquired, 1 tracked investor.
EsoBiotec is a startup founded in 2018 based in Belgium. EsoBiotec has been acquired. Brouky records 1 investor associated with the company.
EsoBiotec develops cancer immunotherapies by engineering immune cells within the patient's body, aiming to improve cancer treatment through its proprietary ENaBL vector platform, which addresses costs and logistics of traditional cell therapies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.